3 active not recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SPI-1005 for the Treatment of Meniere's Disease (Open Label) Ebselen - Meniere's Disease, Ménière's Disease | Phase 3 | Active not recruiting | Sound Pharmaceuticals, Incorporated | 200 | 2025-10-29 | 2026-07-13 |
| Oral N-acetylcysteine for Retinitis Pigmentosa N-acetylcysteine, Placebo - Retinitis Pigmentosa | Phase 3 | Active not recruiting | Johns Hopkins University | 485 | 2023-10-11 | 2026-06-15 |
| ACHIEVE Brain Health Follow-Up Study Hearing intervention, Successful aging/delayed hearing intervention - Aging, Cognitive Decline | Phase 3 | Active not recruiting | Johns Hopkins University | 629 | 2023-01-12 | 2026-07-21 |
Cognitive Dysfunction (1) · Dementia (1) · Dizziness (1) · Meniere Disease (1) · Retinitis Pigmentosa (1) · Tinnitus (1) · Usher Syndromes (1) · Vertigo (1)
Ear Diseases (3) · Hearing Disorders (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Otorhinolaryngologic Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Abnormalities, Multiple (1) · Blindness (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Acetylcysteine (1) · ebselen (1)
Johns Hopkins University (2) · Sound Pharmaceuticals, Incorporated (1)
United States (3) · Austria (1) · Canada (1) · Germany (1) · Netherlands (1) · Switzerland (1) · United Kingdom (1)
Frank R Lin, MD, PhD (1) · Josef Coresh, MD, PhD (1) · Peter A Campochiaro, MD (1) · Xiangrong Kong (1)
1UG1EY033293 (1), R01AG076518 (1)